DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
Sun J, Wang X, Shen Q, Wang M, Chen S, Zhang X, Huang Y, Zhang Z, Li W, Yuan Y, Huang Z.
Sun J, et al. Among authors: zhang z, zhang x.
Cell Oncol (Dordr). 2022 Dec;45(6):1187-1202. doi: 10.1007/s13402-022-00709-1. Epub 2022 Nov 3.
Cell Oncol (Dordr). 2022.
PMID: 36327092